J-CREST (Japan Clinical REtina STudy group), Kagoshima, Japan.
Department of Ophthalmology, Hyogo College of Medicine, Nishinomiya, Japan.
Ocul Immunol Inflamm. 2023 Sep;31(7):1505-1512. doi: 10.1080/09273948.2022.2112237. Epub 2022 Aug 25.
We investigated potential predictive factors for visual prognosis in Japanese patients with endogenous endophthalmitis.
Retrospective observational multicenter cohort study.
We examined the characteristics of 77 Japanese patients with endogenous endophthalmitis and performed statistical analyses of these real-world data. The primary endpoint was the identification of factors associated with visual prognosis. We examined differences between patients in the better vision and legal blindness groups at 12 weeks after treatment initiation.
The five risk factors for visual impairment at 12 weeks after treatment initiation were presence of pressure injuries, severe clinical symptoms (presence of eye pain and ciliary injection), pathogen identification, and poor best-corrected visual acuity at baseline. and fungus were associated with a better visual impairment outcome.
Endogenous endophthalmitis remains a severe ocular infection; however, it can be managed with rapid treatments, as well as other advances in medical knowledge and technology.
我们研究了日本内源性眼内炎患者视觉预后的潜在预测因素。
回顾性观察性多中心队列研究。
我们检查了 77 例日本内源性眼内炎患者的特征,并对这些真实世界数据进行了统计分析。主要终点是确定与视觉预后相关的因素。我们比较了治疗开始后 12 周时视力较好和法定失明组患者之间的差异。
治疗开始后 12 周时视力受损的五个危险因素为存在压疮、严重临床症状(眼痛和睫状充血存在)、病原体鉴定以及基线时最佳矫正视力差。与预后较好的因素包括病原体为细菌和真菌。
内源性眼内炎仍然是一种严重的眼部感染;然而,随着医疗知识和技术的快速发展,可以通过快速治疗以及其他进展来进行管理。